INBAZOME Trademark

Trademark Overview

On Friday, August 5, 2011, a trademark application was filed for INBAZOME with the United States Patent and Trademark Office. The USPTO has given the INBAZOME trademark a serial number of 85390312. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 9, 2015. This trademark is owned by Pfizer Inc.. The INBAZOME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
inbazome

General Information

Serial Number85390312
Word MarkINBAZOME
Filing DateFriday, August 5, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 9, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 6, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, March 9, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 9, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 6, 2015ASSIGNED TO EXAMINER
Wednesday, August 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 5, 2014EXTENSION 5 GRANTED
Wednesday, July 30, 2014EXTENSION 5 FILED
Wednesday, July 30, 2014TEAS EXTENSION RECEIVED
Wednesday, January 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 21, 2014EXTENSION 4 GRANTED
Wednesday, January 8, 2014EXTENSION 4 FILED
Wednesday, January 8, 2014TEAS EXTENSION RECEIVED
Tuesday, August 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2013EXTENSION 3 GRANTED
Wednesday, July 3, 2013EXTENSION 3 FILED
Friday, August 2, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 3, 2013TEAS EXTENSION RECEIVED
Wednesday, May 22, 2013ASSIGNED TO EXAMINER
Wednesday, January 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 22, 2013EXTENSION 2 GRANTED
Thursday, January 17, 2013EXTENSION 2 FILED
Thursday, January 17, 2013TEAS EXTENSION RECEIVED
Monday, January 14, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 26, 2012EXTENSION 1 GRANTED
Wednesday, July 18, 2012EXTENSION 1 FILED
Wednesday, July 18, 2012TEAS EXTENSION RECEIVED
Tuesday, July 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 26, 2012TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 31, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 6, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2011PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 26, 2011ASSIGNED TO EXAMINER
Tuesday, August 9, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 9, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

inbazome preparations pharmaceutical dysfunction treatment disorders erectile diseases urological urogenital sexual